Liminatus Pharma, Inc. (LIMN): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

23.75M
Year ended 2025-12-31
2024-12-31: 17.50M2025-12-31: 23.75M23.75M
2024-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3123.75M+35.7%2026-03-31, From 2025-01-01
2024-12-3117.50Mn/a2026-03-31, From 2024-01-01